Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus

FEMS Microbiology Letters

Volumn 332, Issue 1, 2012, Pages 10-19

  Bowyer, Paul ^a   Mosquera, Juan ^a   Anderson, Michael ^a   Birch, Mike ^b   Bromley, Michael ^a   Denning, David W ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b F2G LTD   (United Kingdom)

Author keywords

Aspergillus; Azole; Resistance

Indexed keywords

AMPHOTERICIN B; FUNGAL DNA; ITRACONAZOLE; POSACONAZOLE; PYRROLE DERIVATIVE; RAVUCONAZOLE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FUMIGATUS; BIOSYNTHESIS; CONTROLLED STUDY; DNA EXTRACTION; ENZYME METABOLISM; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; GENE IDENTIFICATION; GENE INSERTION; MINIMUM INHIBITORY CONCENTRATION; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTOPLAST; SEQUENCE HOMOLOGY; SOUTHERN BLOTTING; START CODON; TRANSCRIPTION REGULATION;

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; BLOTTING, SOUTHERN; CHROMOSOME MAPPING; DRUG RESISTANCE, FUNGAL; GENES, FUNGAL; ITRACONAZOLE; MUTAGENESIS, INSERTIONAL; PHENOTYPE; PLASMIDS;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; FUNGI;

EID: 84862241442     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2012.02575.x     Document Type: Article

References (68)

1. Agrios G (1997) Plant Pathology, 4th edn. pp. 25-36. Significance of plant diseases. Academic Press, San Diego, CA.
2. Balajee SA, Weaver M, Imhof A, Gribskov J & Marr KA (2004) Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals. Antimicrob Agents Chemother 48: 1197-1203.
3. Bolker M, Bohnert HU, Braun KH, Gorl J & Kahmann R (1995) Tagging pathogenicity genes in Ustilago Maydis by restriction enzyme-mediated integration (Remi). Mol Gen Genet 248: 547-552.
4. Brown JS, Aufauvre-Brown A & Holden DW (1998) Insertional mutagenesis of Aspergillus fumigatus Mol Gen Genet 259: 327-335.
5. Calabrese D, Bille J & Sanglard D (2000) A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology 146: 2743-2754.
6. Chandrasekar PH, Cutright JL & Manavathu EK (2001) Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999. Diagn Microbiol Infect Dis 41: 211-214.
7. Chen J, Li H, Li M, Bu RYDF & Wan Z (2005) Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J Antimicrob Chemother 55: 31-37.
8. Chryssanthou E (1997) In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. Acquired resistance to itraconazole. Scand J Infect Dis 29: 509-512.
9. Cui Q & Karplus M (2003) Catalysis and specificity in enzymes: a study of triosephosphate isomerase and comparison with methyl glyoxal synthase. Adv Protein Chem 66: 315-372.
10. Dannaoui E, Borel E, Persat F, Monier MF & Piens MA (1999) In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. J Med Microbiol 48: 1087-1093.
11. Dannaoui E, Borel E, Monier MF, Piens MA, Picot S & Persat F (2001) Acquired itraconazole resistance in Aspergillus fumigatus J Antimicrob Chemother 47: 333-340.
12. Dannaoui E, Meletiadis J, Tortorano AM, Symoens F, Nolard N, Viviani MA, Piens MA, Lebeau B, Verweij PE & Grillot R (2004) Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients. J Med Microbiol 53: 129-134.
13. de Souza CC, Goldman MHD & Goldman GH (2000) Tagging of genes involved in multidrug resistance in Aspergillus nidulans Mol Gen Genet 263: 702-711.
14. Denning DW (1998) Invasive Aspergillosis. Clin Infect Dis 26: 781-803.
15. Denning DW, Venkateswarlu K, Oakley KL, Anderson MJ, Manning NJ, Stevens DA, Warnock DW & Kelly SL (1997a) Itraconazole resistance in Aspergillus fumigatus Antimicrob Agents Chemother 41: 1364-1368.
16. Denning DW, Radford SA, Oakley KL, Hall L, Johnson EM & Warnock DW (1997b) Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother 40: 401-414.
17. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P & Niven RM (2006) The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 27: 615-626.
18. Diaz-Guerra TM, Mellado E, Cuenca-Estrella M & Rodriguez-Tudela JL (2003) A point mutation in the 14 alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus Antimicrob Agents Chemother 47: 1120-1124.
19. Diaz-Guerra TM, Mellado E, Cuenca-Estrella A & Rodriguez-Tudela JL (2004) A point mutation in the 14 alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus Antimicrob Agents Chemother 48: 1071-1071.
20. Diekema DJ, Messer SA, Hollis RJ, Jones RN & Pfaller MA (2003) Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 41: 3623-3626.
21. Drago M, Scaltrito MM, Cariani L & Morace G (2004) In vitro testing of Aspergillus fumigatus clinical isolates for susceptibility to voriconazole, amphotericin B and itraconazole: comparison of sensititre versus NCCLS M38-A using two different inocula. J Chemother 16: 474-478.
22. Ferreira MED, Capellaro JL, Marques ED et al. (2004) In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance. Antimicrob Agents Chemother 48: 4405-4413.
23. Franz R, Kelly SL, Lamb DC, Kelly DE, Ruhnke M & Morshhauser J (1998) Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 42: 3065-3072.
24. Gomez-Lopez AG, Garcia-Effron E, Mellado A, Monzon JL, Rodriguez-Tudela JL & Cuenca-Estrella M (2003) In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp. Antimicrob Agents Chemother 47: 3085-3088.
25. Groll AH, Shah PM, Mentzel C, Schneider M, JustNuebling G & Huebner K (1996) Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 33: 23-32.
26. Guinea J, Pelaez T, Alcala L, Ruiz-Serrano MJ & Bouza E (2005) Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation. Antimicrob Agents Chemother 49: 3495-3497.
27. Gupta VK, Avmeet K, Shankarling P, Neeti A, Panwarand S & Prasad R (1998) Identification of polymorphic mutant alleles of CaMDRI, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation. Curr Genet 34: 192-199.
28. Henry KW, Nickels JT & Edlind TD (2002) ROX1 and ERG regulation in Saccharomyces cerevisiae: implications for antifungal susceptibility eukaryot. Cell 1: 1041-1044.
29. Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC, Laverdiere M, Arendrup MC, Perlin DS & Denning DW (2009) Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 15: 1068-1076.
30. Hsueh PR, Lau YC, Chuang JH et al. (2005) Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: Surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Antimicrob Agents Chemother 49: 512-517.
31. Kauffmann-Lacroix C, Witthuhn F, Dufour X, Klossek JM, Charron M & Rodier MH (2004) Antifungal susceptibility testing of filamentous fungi isolated from upper respiratory tract with the Etest((R)) method. J Mycol Med 14: 75-77.
32. Kelly SL, Lamb DC, Kelly DE, Manning NJ, Loeffler J & Hebart H (1997) Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol α5, 6-desaturation. FEBS Lett 400: 80-82.
33. Kwast KE, Lai LC, Menda N, James DT III, Aref S & Burke PV (2002) Genomic analyses of anaerobically induced genes in Saccharomyces cerevisiae: functional roles of Rox1 and other factors in mediating the anoxic response. J Bacteriol 184: 250-265.
34. Latgé JP & Calderone R (2002) Host-microbe interactions: fungi invasive human fungal opportunistic infections. Curr Opin Microbiol 5: 355-358.
35. Lu S, Lyngholm L, Yang G, Bronson C, Yoder O & Turgeon B (1994) Tagged mutations at the Tox1 locus of Cochliobolus heterostrophus by restriction enzyme-mediated integration. PNAS 91: 12649-12653.
36. Mabey Gilsenan JE, Atherton G, Bartholomew J, Giles PF, Attwood TK, Denning DW & Bowyer P (2009) Aspergillus genomes and the Aspergillus cloud. Nucleic Acids Res 37: D509-D514.
37. Marichal P, Koymans L, Willemsens S, Bellens D, Verhasselt P, Luyten W, Borgers M, Ramaekers FCS, Odds FC & Bossche HV (1999) Contribution of mutations in the cytochrome P450 14 α-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans Microbiology 145: 2701-2713.
38. Marques I, Duarte M, Assunção J, Ushakova AV & Videira A (2005) Composition of complex I from Neurospora crassa and disruption of two "accessory" subunits. Biochim Biophys Acta 1707: 211-220.
39. Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Cuenca-Estrella M & Rodriguez-Tudela JL (2004) Substitutions at methionine 220 in the 14 alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother 48: 2747-2750.
40. Mellado E, Garcia-Effron G, Buitrago MJ, Alcazar-Fuoli L, Cuenca-Estrella M & Rodriguez-Tudela JL (2005) Targeted gene disruption of the 14-{alpha} sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility. Antimicrob Agents Chemother 49: 2536-2538.
41. Moore CB, Sayers N, Mosquera J, Slaven J & Denning DW (2000) Antifungal drug resistance in Aspergillus J Infect 41: 203-220.
42. Nakaune R, Adachi K, Nawata O, Tomiyama M, Akutsu K & Hibi T (1998) A novel ATP-binding cassette transporter involved in multidrug resistance in the phytopathogenic fungus Penicillium digitatum Appl Environ Microbiol 64: 3983-3988.
43. Nascimento AM, Goldman GH, Park S, Marras SAE, Delmas G, Oza K, Lolans U, Dudley MN, Mann PA & Perlin DS (2003) Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob Agents Chemother 47: 1719-1726.
44. Nierman WC, Pain A, Anderson MJ et al. (2005) Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus Nature 438: 1151-1156.
45. Nolte FS, Parkinson T, Falconer DJ, Dix S, Williams J, Gilmore C, Geller R & Wingard JR (1997) Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob Agents Chemother 41: 196-199.
46. Oerke E-C & Dehne H-W (2004) Safeguarding production-losses in major crops and the role of crop protection. Crop Prot 23: 275-285.
47. Oerke E-C, Dehne H-W, Schonbeck F & Weber A (1994) Crop Production and Crop Protection-Estimated Losses in Major Food and Cash Crops. pp. 808. Elsevier Science, Amsterdam.
48. Osherov N, Kontoyiannis DP, Romans A & May GS (2001) Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14alpha-demethylase gene, pdmA. J Antimicrob Chemother 48: 75-81.
49. Pfaller MA, Boyken L, Hollis RJ, Messer SA, Tendolkar S & Diekema DJ (2005) In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9, 359 isolates tested by clinical and laboratory standards institute broth microdilution methods. J Clin Microbiol 43: 3807-3810.
50. Pfaller MA, Diekema DJ & Sheehan DJ (2006) Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev 19: 435-447.
51. Rigoulet M, Aguilaniu H, Avéret N, Bunoust O, Camougrand N, Grandier-Vazeille X, Larsson C, Pahlman IL, Manon S & Gustafsson L (2004) Organization and regulation of the cytosolic NADH metabolism in the yeast Saccharomyces cerevisiae Mol Cell Biochem 256-257: 73-81.
52. Robson G, Wiebe M, Cunliffe B & Trinci A (1995) Choline- and acetylcholine-induced changes in the morphology of Fusarium graminearum: evidence for the involvement of the choline transport system and acetylcholinesterase. Microbiology 141: 1309-1314.
53. Sánchez O, Navarro RE & Aguirre J (1998) Increased transformation frequency and tagging of developmental genes in Aspergillus nidulans by restriction enzyme-mediated integration (REMI). Mol Gen Genet 258: 89-94.
54. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M & Bille J (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39: 2378-2386.
55. Sanglard D, Ischer F, Monod M & Bille J (1997) Cloning of Candida albicans genes conferring resistance to azole antifungal agents characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143: 405-416.
56. Schaller M, Schafer W, Korting HC & Hube B (1998) Differential expression of secreted aspartyl proteinases in a model of human oral candidiasis and in patient samples from the oral cavity. Mol Microbiol 29: 605-615.
57. Slaven JW, Anderson MJ, Sanglard D, Dixon GK, Bille J, Roberts IS & Denning DW (2002) Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet Biol 36: 199-206.
58. Turner GE, Jimenez TJ, Chae SK, Baasiri RA & Borkovich KA (1997) Utilization of the Aspergillus nidulans pyrG gene as a selectable marker for transformation and electroporation of Neurospora crassa Fungal Genet Newsl 47: 57-59.
59. Ushakova AV, Duarte M, Vinogradov AD & Videira A (2005) The 29.9 kDa subunit of mitochondrial complex I is involved in the enzyme active/de-active transitions. J Mol Biol 351: 327-333.
60. Verweij PE, Mensink M, Rijs A, Donnelly JP, Meis J & Denning DW (1998) In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates. J Antimicrob Chemother 42: 389-392.
61. Verweij PE, Dorsthorst D, Rijs AJ, De Vries-Hospers HG & Meis J (2002) Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998. J Clin Microbiol 40: 2648-2650.
62. Videira A & Duarte M (2002) From NADH to ubiquinone in Neurospora mitochondria. Biochim Biophys Acta 1555: 187-191.
63. Vogeser M, Wanders A, Haas A & Ruckdeschel G (1999) A four-year review of fatal aspergillosis. Eur J Clin Microbiol Infect Dis 18: 42-45.
64. Warris A, Weemaes CM & Verweij PE (2002) Multidrug resistance in Aspergillus fumigatus N Engl J Med 347: 2173-2174.
65. Wright GD, Parent T & Honek JF (1990) Non-sterol structural probes of the lanosterol 14α-demethylase from Saccharomyces cerevisiae Biochim Biophys Acta 1040: 95-101.
66. Yang Y-L & Lo J-L (2001) Mechanisms of antifungal agent resistance. J Microbiol Immunol Infect 34: 79-86.
67. Yoshida Y & Aoyama Y (1984) Yeast cytochrome P-450 catalyzing lanosterol 14α-demethylation. J Biol Chem 259: 1655-1660.
68. 14DM purified from Saccharomyces cerevisiae microsomes. Biochem Pharmacol 36: 229-35.